509 related articles for article (PubMed ID: 30049286)
1. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
[TBL] [Abstract][Full Text] [Related]
2. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
3. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
7. Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis.
Xu ML; Liu TC; Dong FX; Meng LX; Ling AX; Liu S
Aging (Albany NY); 2021 Aug; 13(15):19776-19788. PubMed ID: 34370713
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer.
Zhang W; Cai X; Yu J; Lu X; Qian Q; Qian W
Int J Oncol; 2018 Aug; 53(2):527-538. PubMed ID: 29845246
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
11. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
12. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
13. Restoration of circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis.
Zhu H; Du F; Cao C
Cell Biol Int; 2021 Jan; 45(1):107-116. PubMed ID: 32997362
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
Du F; Guo T; Cao C
Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
18. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
Li FZ; Zang WQ
World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
